ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0453

Validation of the 2022 – American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria in Patients with ANCA Associated Vasculitis

Aman Sharma1, Prateek Deo1, Shankar Naidu2, Joydeep Samanta3, Sakshi Mittal3, Kusum Sharma3, Ritambhra Nada3, Varun Dhir4, sanjay jain2 and Ranjana Minz2, 1PGIMER, Chandigarh, India, Chandigarh, India, 2Postgraduate Institute of Medical Education and Research, Chandigarh, India, 3PGIMER, Chandigarh, India, 4PGIMER, CHD, INDIA, Chandigarh, India

Meeting: ACR Convergence 2022

Keywords: ANCA associated vasculitis, classification criteria, Eosinophilic Granulomatosus with Polyangiitis (Churg-Strauss), Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – ANCA-Associated Poster I: Epidemiology, Outcomes, and Classification

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: The purpose of this study was to validate the recently published 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for classification of ANCA associated vasculitis/AAV (Granulomatosis with Polyangiitis [GPA], Eosinophilic Granulomatosis with Polyangiitis [EGPA] and Microscopic Polyangiitis [MPA])

Methods: Patients with a diagnosis of AAV from Indian vasculitis registry (INVAR) cohort were included in the study. The new 2022 ACR classification criteria of AAV[1]–[3], 1990 ACR classification criteria for GPA and EGPA, and the EMA Algorithm were validated in our cohort to assess their performance. The level of agreement was assessed using Cohen’s kappa. The clinician’s diagnosis was considered as the gold standard.

Results: A total of 302 patients diagnosed AAV with mean age of 42.87 ± 14.7 years were included. 58.7% were females and 42.3 % were males. Table 1 and Figure 1 show the distribution of AAV patients classified according to various classification criteria. The new ACR 2022 criteria for GPA (kappa: 0.961; sensitivity: 99% and specificity: 99%), MPA (kappa: 0.992, sensitivity: 99.9% and specificity: 99.9%), EGPA (kappa:0.961, sensitivity: 92% and 100%) had almost perfect agreement with INVAR cohort. Table 2 shows performance of EMA algorithm and the ACR 1990 criteria compared to the new 2022 classification criteria for AAV in the INVAR cohort. Furthermore, predominant CNS or ocular GPA (if PR3/MPO negative) were missed by the new ACR classification criteria. EMA Algorithm missed cases of ANCA vasculitis where histology was not possible or ANCA was positive by IIF.

Conclusion: The study showed the new criteria for AAV, had good performance in INVAR registry AAV patients. The new criteria had good sensitivity and specificity for classification of GPA, MPA and EGPA compared to EMA algorithm.

References:

  1. Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis. Arthritis Rheumatol. 2022;74(3):400–6.
  2. Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis. Arthritis Rheumatol.2022;74(3):393–9.
  3. Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Arthritis Rheumatol. 2022;74(3):386–92.

Supporting image 1

Table 1: Table showing distribution of AAV patients according to various classification criteria, total patients, n=302

Supporting image 2

Table showing sensitivity and specificity of the EMA algorithm and the ACR 1990 Criteria compared to the new 2022 classification criteria for AAV in the INVAR cohort

Supporting image 3

Figure 1: Venn Diagram showing classification of AAV in INVAR cohort according to various classification criteria


Disclosures: A. Sharma, None; P. Deo, None; S. Naidu, None; J. Samanta, None; S. Mittal, None; K. Sharma, None; R. Nada, None; V. Dhir, None; s. jain, None; R. Minz, None.

To cite this abstract in AMA style:

Sharma A, Deo P, Naidu S, Samanta J, Mittal S, Sharma K, Nada R, Dhir V, jain s, Minz R. Validation of the 2022 – American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria in Patients with ANCA Associated Vasculitis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/validation-of-the-2022-american-college-of-rheumatology-european-alliance-of-associations-for-rheumatology-classification-criteria-in-patients-with-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-the-2022-american-college-of-rheumatology-european-alliance-of-associations-for-rheumatology-classification-criteria-in-patients-with-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology